Sale!

GAN Gene Giant Axonal Neuropathy Type 1 Genetic Test

4,400 د.إ

-21%

The GAN Gene Giant Axonal Neuropathy Type 1 Genetic Test is a specialized diagnostic examination available at DNA Labs UAE, aimed at detecting mutations in the GAN gene, which are responsible for Giant Axonal Neuropathy (GAN) Type 1. This rare, inherited neurological disorder is characterized by a progressive decline in nerve function, affecting both the central and peripheral nervous systems. Symptoms typically emerge in early childhood and can include muscle weakness, motor skill regression, and in severe cases, impairment of sensory functions.

The test is crucial for early diagnosis and management of the condition, offering insights into potential treatments and interventions that can improve quality of life. Conducted through a detailed analysis of the patient’s DNA, it seeks to identify specific genetic alterations in the GAN gene that confirm the diagnosis of GAN Type 1.

The cost of the GAN Gene Giant Axonal Neuropathy Type 1 Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive genetic screening process, leveraging advanced technology and expertise to ensure accurate and reliable results. Given the complexity and rarity of the condition, this genetic test represents a critical step towards personalized care and management for affected individuals and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GAN Gene Giant Axonal Neuropathy Type 1 Genetic Test

Test Name: GAN Gene Giant Axonal Neuropathy Type 1 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for GAN Gene Giant Axonal Neuropathy Type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GAN Gene Giant Axonal Neuropathy Type 1.

Test Details

GAN Gene Giant Axonal Neuropathy Type 1 NGS Genetic Test is a type of genetic test that detects mutations in the GAN gene, which is associated with Giant Axonal Neuropathy (GAN) type 1. GAN is a rare genetic disorder that affects the nervous system, causing progressive muscle weakness and loss of sensation.

The NGS (Next-Generation Sequencing) technology used in this test allows for the simultaneous analysis of multiple genes, providing a more comprehensive and accurate diagnosis. This test can help identify individuals who are at risk of developing GAN or carriers of the disease, allowing for early detection and appropriate management.

Test Name GAN Gene Giant axonal neuropathy type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GAN Gene Giant axonal neuropathy type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GAN Gene Giant axonal neuropathy type 1
Test Details

GAN Gene Giant axonal neuropathy type 1 NGS Genetic Test is a type of genetic test that detects mutations in the GAN gene, which is associated with Giant Axonal Neuropathy (GAN) type 1. GAN is a rare genetic disorder that affects the nervous system, causing progressive muscle weakness and loss of sensation. The NGS (Next-Generation Sequencing) technology used in this test allows for the simultaneous analysis of multiple genes, providing a more comprehensive and accurate diagnosis. This test can help identify individuals who are at risk of developing GAN or carriers of the disease, allowing for early detection and appropriate management.